Abbreviations GI, gastrointestinal
They work by controlling blood sugar levels through similar mechanisms, like increasing insulin release, delaying gastric emptying, and suppressing glucagon (which stimulates blood sugar)
side effects Some report excellent results at lower doses (1.2-1.8mg) Higher doses (3.0mg+) provide marginal additional benefit for some but increased side effects for others Weekly dosing preferred over more frequent administration Combination Experiences: Cagrilintide with GLP-1 agonists (semaglutide, tirzepatide) frequently reported Users report synergistic appetite suppression with combinations Side effects more pronounced with combinations but manageable with gradual escalation Some researchers alternate peptides rather than using simultaneously What Researchers Say About Cagrilintide Blend with Retatrutide While specific reports of cagrilintide blend with retatrutide remain limited due to retatrutide's recent development, researchers who have used both compounds separately note: "Retatrutide provided the strongest weight loss I've experienced, but adding cagrilintide would theoretically address the appetite rebound some experience at lower retatrutide doses." "The combination makes sense mechanistically retatrutide handles the metabolic side while cagrilintide manages appetite through a completely different pathway." "Both compounds can cause significant nausea initially
The peak is middle age More than 1 in 5 adults aged 50 to 64 (22%) currently take a GLP-1, against just 4% of adults under 30
Son, J., Lee, J
For example, one study found that consumption of green tea is associated with a reduced risk of abdominal obesity in women
